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Significant	 age	 and	 experience-dependent	 remodelling	 of	 spinal	 and	 supraspinal	 neural	 networks	
occur	 resulting	 in	 altered	 pain	 responses	 in	 early	 life.	 In	 adults	 endogenous	 opioid	 peptide	 and	
endocannabinoid	(ECs)	pain	control	systems	exist	which	modify	pain	responses	but	the	role	they	play	
in	acute	responses	to	pain	and	postnatal	neurodevelopment	is	unknown.	Here	we	have	studied	the	
changing	 role	of	 the	ECs	 in	brainstem	nuclei	 essential	 for	 the	 control	of	nociception	 from	birth	 to	
adulthood	in	both	rat	and	human.	Using	in	vivo	electrophysiology	we	show	that	substantial	functional	





2-arachidonoylglycerol	 within	 the	 PAG	 and	 RVM	 are	 developmentally	 regulated	 (using	 mass	
spectrometry).	The	expression	patterns	and	levels	of	ECs	enzymes	and	receptors	were	assessed	using	
quantitative	PCR	and	immunohistochemistry.	In	human	brainstem	we	show	age-related	alterations	in	






Pain	 in	 infancy	 is	a	clinical	concern	and	has	been	recognised	as	being	sub-optimally	managed	[60].	
Previous	 studies	 have	 shown	 that	 pain	 processing	 in	 young	 mammals	 is	 immature:	 nocifensive	
withdrawal	thresholds	are	lower,	and	response	magnitudes	are	greater	and	longer	lasting	during	early	
life	 [22].	Normal	 adult	 processing	 of	 noxious	 sensory	 inputs	 requires	 a	 constant	 balance	 between	
synaptic	excitation	and	inhibition	within	the	somatosensory	pathway	[17;	58].	Descending	modulatory	
pathways,	specifically	the	spino-bulbo-spinal	 loop,	plays	a	key	role	in	modulating	spinally	mediated	




postnatal	maturation	and	 immature	pain	behaviours	 are	partly	 explained	by	 the	predominance	of	
synaptic	excitation	over	inhibition	within	the	DH	[1;	21;	23;	28;	30;	38;	39;	54].		Opioidergic	activity	





are	antinociceptive	 [20;	34;	41],	 and	 this	 effect	 is	 known	 to	be	mediated	via	 the	CB1	 cannabinoid	
receptor	[13].	The	other	cannabinoid	receptor,	CB2,	is	mainly	expressed	by	peripheral	immune	cells	
[50].	However,	CB2	receptor	is	also	expressed	by	neurons	and	glial	cells	within	the	brainstem	and	DH,	






utero,	 guiding	 neuronal	 and	 glial	 migration,	 axon	 elongation	 and	 synaptogenesis	 [27]	 [52].	 More	
importantly,	the	role	of	the	EC	signalling	system	in	neurodevelopment	and	maturation	continues	after	













cages	 in	 an	 in-house	 animal	 facility.	 Free	 access	 to	 food	 and	water	 was	 available	 throughout.	 All	
experiments	were	performed	in	P10,	P21	and	P40	rats	during	the	animals’	light	cycle.	Experimental	























kept	 at	 1.3%	 to	maintain	 light	 anaesthesia,	 as	previously	described	 [29;	 39].	 The	 fur	overlying	 the	
biceps	 femoris	 muscle	 was	 trimmed	 and	 a	 bipolar	 concentric	 needle	 EMG	 recording	 electrode	
(comprising	a	modified	27-gauge	hypodermic	needle;	Ainsworth,	Coventry,	UK)	inserted	into	the	belly	










presentations	 recorded.	 Different	 hairs	 were	 used	 in	 each	 age	 group	 as	 mechanical	 withdrawal	


























laboratories.	 	 Tissue	was	 selected	 to	 come	 from	 cases	 aged	 25-29	weeks	 gestation,	 38-39	weeks	
gestation	and	older	than	2	years.		Cause	of	death	was	provided	and	included	transcervical	ascending	










Biosystems,	 Forster	 City,	 CA,	 USA).	 Primers	 and	 probes	 for	 glyceraldehyde	 3-phosphate	
dehydrogenase	(GAPDH;	National	Center	for	Biotechnology	 Information	[NCBI]	reference	sequence	
NM_017008.3),	 CB1	 receptor	 (NM_012874.4),	 CB2	 receptor	 (NC_005104.4),	 GPR55	 receptor	
(XM_006245494.1),	NAPE-PLD	(NM_199381.1)	and	DAGLα	(NM_006133.2)	were	designed	on	Primer	
Express	3	(Applied	Biosystems).	Each	sample	was	run	in	triplicates.	Expression	of	target	genes	were	























All	 individual	data	points	were	 represented	as	mean	±	 SEM.	EMG	data	were	normally	distributed.	
Statistical	comparisons	between	the	age	groups	and	drugs	were	made	using	two-way	ANOVA	or	one-
way	ANOVA	with	Bonferroni	multiple	comparisons.	Statistical	comparison	between	the	age	groups	for	






liquid	 chromatography-mass	 spectrometry	 (LC-MS/MS).	 In	 the	 PAG	 (Fig	 1A)	 and	 RVM	 (Fig	 1B)	 the	
levels	of	AEA	significantly	increased	during	the	early	postnatal	period,	and	reached	mature	levels	by	
P21.	Similarly	2-AG	levels	in	the	PAG	(Fig	1C)	and	RVM	(Fig	1D)	also	increased	and	reached	mature	
levels	 by	 P21.	 Consistent	 with	 previous	 reports,	 the	 measured	 concentration	 of	 2-AG	 is	 higher	
compared	to	anandamide	in	the	brain	regions	tested,	as	AEA	is	measured	in	pmol/g	range	whereas	2-
AG	 in	 nmol/g	 range	 [8].	 Collectively	 these	 data	 indicate	 that	 the	 expression	of	 ECs	 increases	with	
postnatal	age	of	the	rat.		
Oleoylethanolamine	 (OEA)	 and	 palmitoylethanolamine	 (PEA)	 were	 also	 measured	 (Supp.	 Fig.	 1).	
Although	OEA	and	PEA	lack	affinity	at	CB1	and	CB2	receptors	[10],	they	exert	similar	effects	as	other	
synthetic	 cannabinoids,	 via	 the	 peroxisome	 proliferator-activated	 receptor-alpha	 (PPAR-α),	 GPR55	
and	GPR119	receptors	[13;	57].	There	were	no	changes	in	PEA	levels	in	the	PAG	(Supp.	Fig.	1A),	but	
PEA	 levels	 in	 the	 RVM	 increased	with	 postnatal	 age	 and	was	 highest	 in	 P40s	 (Supp.	 Fig.	 1B).	 The	
concentration	of	OEA	in	the	PAG	and	RVM	also	increased	with	postnatal	age	and	similarly,	expression	
was	highest	in	P40s	(Supp.	Fig.	1C,	D).		
We	 next	 assessed	 whether	 the	 expression	 of	 endocannabinoid	 synthesising	 enzymes	 N-acyl	
phosphatidylethanolamine-specific	 phospholipase	 D	 (NAPE-PLD;	 synthesising	 anandamide)	 and	






In	 the	 vPAG,	 NAPE-PLD	mRNA	 transcript	 levels	 increased	 as	 the	 rats	 aged,	 and	 NAPE-PLD	mRNA	
transcript	 levels	 were	 higher	 in	 P40s	 compared	 to	 P10	 (Fig.	 1E).	 No	 differences	 in	 DAGLα	mRNA	
transcript	levels	(Fig.	1E)	were	observed	in	the	vPAG	between	the	ages.	In	the	RVM,	no	differences	in	
DAGLα	and	NAPE-PLD	mRNA	transcript	levels	were	observed	between	the	ages	(Fig.	1F).	
To	 investigate	whether	our	 results	 are	 translational	 in	humans,	we	also	measured	mRNA	 levels	of	
NAPE-PLD	 in	 the	midbrain	of	post-mortem	human	 tissue	deposited	 in	 the	Nottingham	BioBank	by	
TaqMan	qRT-PCR.	Tissues	were	selected	to	span	a	range	of	ages	from	subjects	that	were	born	pre-
term	 (24-26	 weeks	 post-conceptional	 age,	 n=8),	 full-term	 (39-40	 weeks	 post-conceptional,	 n=8),	
infants	 (3-8	 months,	 n=8)	 and	 adults	 (14-60	 years,	 n=4).	 mRNA	 levels	 were	 measured	 using	 a	
	 7	
geometric	mean	 of	 reference	 genes	 (cyclophilin	 A	 and	 hydroxymethylbilane	 synthase).	We	 found	
NAPE-PLD	mRNA	transcript	level	was	higher	in	infants	compared	to	both	pre-term	and	full-term	(Fig.	









significance	 (Fig.	 2A).	 Immunohistochemistry	 demonstrated	 CB1	 staining	was	mostly	 diffuse	 fibres	




observed	 (Fig.	 2D).	 However	 using	 immunohistochemistry	 we	 found	 significant	 differences	 in	 the	







In	 the	 human	midbrain,	 no	 changes	 in	 the	 expression	 of	 either	 CB1	 or	 CB2	 receptor	mRNA	were	
observed	 (Fig.	 4A,	 B).	 To	 examine	 the	 pattern	 of	 mRNA	 expression	 in	 human	 tissue,	 in	 situ	
hybridisation	 techniques	were	used	 to	 investigate	 the	expression	of	CB1	and	CB2	 receptors	 in	 the	











The	 functional	 significance	 of	 the	 developing	 EC	 signalling	 system	 on	 nociceptive	 reflexes	 were	
investigated	by	pharmacologically	activating	cannabinoid	receptors	within	brainstem	nuclei	in	lightly-
	 8	
anaesthetised	 rats	 at	 different	 developmental	 timepoints.	 Various	 synthetic	 cannabinoids	 were	
microinjected	into	either	the	vPAG	or	the	RVM	of	each	rat,	and	electromyographic	(EMG)	recordings	
were	 performed	 before	 and	 after	 drug	 administration	 in	 the	 bicep	 femoris	 muscle	 to	 assess	
withdrawal	reflexes	to	mechanical	stimulation	of	the	hindpaw	using	callibrated	von	Frey	hairs	(vFh).	
In	our	first	experiment,	WIN55212	(4μg,	CB1	and	CB2	receptor	agonist)	was	microinjected	into	the	
PAG	of	postnatal	day	 (P)21	and	P40	 rats,	as	previously	experiments	 showed	a	 functional	 switch	 in	
descending	pain	modulation	between	these	ages	(Supp.	Fig.	2)	[29;	30;	39;	55].	Intra-PAG	WIN55212	
significantly	 reduced	 spinal	 reflex	 excitability	 (Supp.	 Fig.	 2C)	 and	 increased	mechanical	withdrawal	







seen	 when	 HU210	 was	 microinjected	 in	 the	 RVM	 (Fig.	 5	 C&D).	 Intra-PAG	 HU210	 induced	 anti-
nociceptive	 effects	 were	 stronger	 in	 P21	 and	 P40	 animals	 compared	 to	 P10	 (Fig.	 5A,	 B)	 with	 the	
greatest	effect	of	HU210	being	observed	at	P21	(Fig.	5C,	D).		
	
Collectively	 these	 data	 showed	 that	 functional	 activation	 of	 CB1	 and	 CB2	 receptors	 within	 the	
descending	pain	pathway	 is	anti-nociceptive	 throughout	postnatal	development.	 In	addition,	 some	
age-related	differences	were	observed	(increased	efficacy	of	HU210	at	P21),	which	suggest	that	EC	
signalling	 via	 the	 CB1	 and	 CB2	 receptors	 undergo	 significant	 refinement	 over	 the	 early	 postnatal	
period.	
Supraspinal	GPR55	receptor	mediated	analgesia	in	early	life	
We	 next	 tested	 the	 effects	 of	 decreasing	 cannabinoid	 receptor	 activity	 on	 nociceptive	 processing	












mechanical	 withdrawal	 threshold	 in	 P21	 rats	 (Fig.	 6B).	 Intra-RVM	 LPI	 significantly	 reduced	 reflex	
excitability	in	P10	and	P21	rats	compared	to	controls	(Fig	6C)	and	increased	mechanical	withdrawal	
thresholds	 in	 both	 P10	 and	 P21	 rats	 (Fig.	 6D).	 In	 P40	 rats,	 neither	 intra-PAG	 nor	 intra-RVM	
	 9	
microinjection	 of	 LPI	 had	 an	 effect	 on	 mechanical	 withdrawal	 thresholds,	 but	 intra-RVM	 LPI	
significantly	increased	spinal	reflex	excitability	when	compared	to	vehicle	controls.	
To	fully	elucidate	whether	AM251	was	acting	via	the	GPR55	receptors,	and	address	the	concern	of	




GPR55	 antagonist,	ML	 193	 (1µg).	 	 Co-administration	 of	ML193	with	AM251	 (1.35µg)	 reversed	 the	
ability	of	AM251	to	decrease	spinal	excitability	in	P21	rats	(Fig	6E).	Moreover,	a	significant	decrease	
in	spinal	reflex	excitability	was	observed	with	both	the	lower	dose	(1.35µg)	and	higher	dose	(2.77	µg)	










in	 the	 midbrain	 of	 humans	 and	 brainstem	 nuclei	 of	 the	 rat,	 and	 these	 changes	 have	 significant	












NAPE-PLD	mRNA	 in	 the	midbrain	was	highest	 in	 infants	 compared	 to	both	pre-term	and	 full-term	
neonates.	Altogether,	these	findings	suggest	that	expression	of	AEA	increases	within	brainstem	nuclei	
of	 mammals	 during	 postnatal	 development.	 Importantly,	 due	 to	 the	 nature	 of	 human	 tissue	 we	
obtained	 for	 this	 study,	early	 life	 inflammation	 could	also	 contribute	 to	 changes	 in	 the	expression	





No	 changes	 were	 detected	 in	 the	 expression	 of	 DAGLα	 mRNA	 within	 the	 brainstem	 nuclei.	 The	
disparity	 between	DAGLα	 expression	 pattern	 and	 levels	 of	 2-AG	may	 be	 explained	 by	 the	 greater	
availability	 of	 the	 substrate	 for	 the	 production	 of	 2-AG	 or	 to	 age-related	 post-translational	
modifications,	it	has	been	shown	that	2-AG	can	be	synthesised	independently	of	DAGLα	activity:	PIP2	
can	 be	 catalysed	 into	 2-arachidonoya-lysophospholipid	 by	 phospholipase	 A1,	 which	 is	 in	 turn	
hydrolysed	by	lyso-PLC	to	become	2-AG	[47].		
The	expression	of	cannabinoid	receptors	within	the	brainstem	nuclei	during	postnatal	development	
We	 did	 not	 find	 significant	 changes	 in	 the	 expression	 of	 either	 CB1	 or	 CB2	 receptor	 mRNA	 with	
postnatal	age,	in	both	rats	and	humans.	However,	in	situ	hybridisation	experiments	showed	that	the	
number	 CB1	 receptor	 positive	 cells	 in	 human	 midbrain	 were	 highest	 during	 infancy	 and	
immunohistochemical	 expression	 of	 CB1	 receptor	 underwent	 postnatal	 modification	 within	 the	
brainstem	nuclei	of	the	rat.	In	line	with	previous	published	findings	[7;	18],	within	the	rat	PAG,	CB1	
receptor	 expression	 were	 found	 closely	 along	 the	 lining	 of	 the	 aqueduct,	 and	 staining	 intensity	
decreased	as	 the	animals	agedWe	also	 found	an	 increase	 in	CB1	receptor	 immunoreactivity	 in	 the	
RVM,	The	disparity	between	mRNA	and	immunohistochemical	data	implies	that	changes	in	expression	
and	function	of	the	receptor	may	reflect	differences	in	the	translation	of	mRNA	rather	than	changes	













In	 this	 study,	 we	 examined	 the	 role	 of	 cannabinoid	 receptors	 in	 the	 brainstem	 on	 nociceptive	
processing	 during	 postnatal	maturation.	We	 pharmacologically	manipulated	 cannabinoid	 receptor	
activity	by	in	vivo	intra-cerebral	microinjections.	Whilst	we	specifically	targeted	the	vlPAG	and	RVM,	
there	is	a	slight	possibility	that	the	drugs	we	administered	could	potentially	diffuse	into	neighbouring	
regions	 within	 the	 brainstem.	 Nonetheless,	 we	 showed	 that	 activation	 of	 CB1/2	 receptors	 in	 the	
brainstem	regions	at	any	of	the	ages	tested	was	always	inhibitory.	Initially	WIN55212	was	injected	into	
the	PAG	of	P21	and	P40	rats,	which	was	antinociceptive	in	both	ages.	HU210	was	used	in	subsequent	
experiment	as	a	CB1/CB2	agonist	because	HU210	 is	about	a	hundred	 fold	more	potent	at	 the	CB1	
receptors	than	WIN55212	(Ki	for	CB1	receptors,	HU210	=	0.061nM,	WIN55212	=	62.3nM).	Application	





















rats	 with	 the	 specific	 GPR55	 receptor	 antagonist	 ML	 193.	 	 The	 general	 consensus	 is	 that	 GPR55	
receptor-mediated	activity	is	most	likely	to	be	pro-nociceptive	in	mature	animals	[16].	The	receptor	in	
the	mature	CNS	is	coupled	to	the	Gq	proteins,	and	when	activated	causes	an	increase	in	intracellular	



























































































































































































































Fig.	 1	 Changes	 in	 the	 expression	 of	 endocannabinoids	 (eCBs)	 and	 eCB-synthesising	 enzymes	 in	






P21	 in	 the	RVM	(D;	p<0.01;	one-way	ANOVA).	 (E)	Taqman	RT-PCR	analysis	of	 the	eCB-synthesising	
enzymes	NAPE-PLD	and	DAGLα	in	vPAG.	The	expression	of	NAPE-PLD	mRNA	increased	during	early	












White	 arrows	denote	CB1	 specific	 terminal	 staining.	 The	 expression	of	 CB1	 receptors	 in	 the	 vPAG	




of	CB1	 receptors	 in	 the	RVM	 increased	as	 the	animals	aged	 (p<0.01-0.001,	one-way	ANOVA)	 (C,	D	
))N=3-5	animals	per	age	group.	Data	shown	here	represent	mean	±	SEM.		*,	**,	***,	****	=	p<0.05;	









Fig.4	 Changes	 in	 the	 expression	 of	 endocannabinoid	 receptors	 CB1	 and	 CB2	 in	 human	midbrain	
during	 postnatal	maturation.	 (A,	 B)	 TaqMan	 RT-PCR	 analysis	 of	 CB1	 and	 CB2	 receptor	mRNA,	 no	
significant	 changes	 in	 were	 detected.	 (C)	 In	 situ	 hybridisation	 images	 (x20	 magnification)	 of	 CB1	
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HU210	 decreased	 spinal	 reflex	 excitabilities	 compared	 to	 vehicle	 responses	 in	 all	 ages	 tested	
(p<0.0001,	 two-way	 ANOVA).	 This	 effect	 was	 strongest	 in	 P21	 animals.	 (D)	 Intra-RVM	 HU210	











in	 either	P10	or	 P40	 rats,	 but	 significantly	 increased	 it	 in	P21	animals.	 There	 are	 significantly	 age-
related	 differences	 in	 AM251	 and	 LPI	 mediated	 changes	 in	 mechanical	 withdrawal	 thresholds	
(p<0.001,	two-way	ANOVA).	(C)	Intra-RVM	AM251	did	not	have	an	effect	in	P40	rats,	but	significantly	
reduced	spinal	reflex	excitabilities	 in	P10	and	P21	animals.	LPI	 increased	spinal	reflex	excitability	 in	
P40	 rats,	 but	 decreased	 it	 in	 P10	 and	 P21	 animals.	 These	 age-related	 differences	were	 significant	
(p<0.0001,	 two-way	 ANOVA).	 (D)	 Intra-RVM	 AM251	 and	 LPI	 significantly	 increased	 mechanical	
threshold	 in	 P10	 and	 P21	 rats,	 but	 had	 no	 effect	 in	 P40	 animals.	 This	 age-related	 difference	was	
significant	(p<0.0001,	two-way	ANOVA).	(E)	Intra-PAG	AM251	(2.77	and	1.35μg)	did	not	have	an	effect	
in	P40,	but	significantly	inhibited	spinal	reflex	excitability	in	P21	animals	(p<0.0001,	one-way	ANOVA).	
Co-administration	 of	 AM251	 (1.35μg)	 with	 the	 GPR55	 receptor	 specific	 antagonist	 ML193	 (1μg)	
reversed	 AM251-mediated	 inhibition	 of	 spinal	 reflex	 excitability	 in	 P21	 animals.	 	 **,	 ***,	 ****	 =	
p<0.01,	p<0.001	and	p<0.0001	respectively,	between	drug	comparisons,	two-way	ANOVA	and	one-
way	ANOVA	with	Bonferroni	multiple	comparisons.	###.	####	=	p<0.001	and	p<0.0001	respectively,	
between	 age	 comparison,	 two-way	 ANOVA	 and	 one-way	 ANOVA	 with	 Bonferroni	 multiple	
comparisons.	
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